Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer
- 1 January 2006
- journal article
- Published by Elsevier in Cancer Detection Prevention
- Vol. 30 (5) , 395-402
- https://doi.org/10.1016/j.cdp.2006.04.009
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Genomics of lung cancer may change diagnosis, prognosis and therapyPathology and Oncology Research, 2005
- S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomasBritish Journal of Cancer, 2004
- Biomarkers in non-small cell lung cancer preventionEuropean Journal Of Cancer Prevention, 2004
- Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and ControlJNCI Journal of the National Cancer Institute, 2003
- Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancerLung Cancer, 2003
- Molecular Pathogenesis of Lung CancerAnnual Review of Physiology, 2002
- Modeling of long-term screening for lung carcinomaCancer, 2001
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Lung Cancer Screening: The Mayo ProgramJournal of Occupational and Environmental Medicine, 1986
- Screening for Early Lung CancerChest, 1984